Evolus, Inc. Common Stock (EOLS) — Analysis Summary
Evolus, Inc. Common Stock (EOLS) has a market cap of $354.96M with year-over-year revenue growth of +31.8%. Net margin stands at -18.9%. The stock trades at a P/E ratio of -7.0.
Key Takeaways
- Revenue changed +31.8% year-over-year
- Net margin of -18.9%
- P/E ratio of -7.0
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, EOLS posted revenue growth of +31.8% and trades at a P/E of -7.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.